Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 6
2004 9
2005 9
2006 8
2007 19
2008 7
2009 10
2010 17
2011 22
2012 15
2013 12
2014 17
2015 11
2016 17
2017 11
2018 19
2019 23
2020 15
Text availability
Article attribute
Article type
Publication date

Search Results

221 results
Results by year
Filters applied: . Clear all
Page 1
Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors.
Altai M, Liu H, Ding H, Mitran B, Edqvist PH, Tolmachev V, Orlova A, Gräslund T. Altai M, et al. Among authors: tolmachev v. J Control Release. 2018 Oct 28;288:84-95. doi: 10.1016/j.jconrel.2018.08.040. Epub 2018 Aug 30. J Control Release. 2018. PMID: 30172673
CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models.
Huizing FJ, Garousi J, Lok J, Franssen G, Hoeben BAW, Frejd FY, Boerman OC, Bussink J, Tolmachev V, Heskamp S. Huizing FJ, et al. Among authors: tolmachev v. Sci Rep. 2019 Dec 11;9(1):18898. doi: 10.1038/s41598-019-54824-5. Sci Rep. 2019. PMID: 31827111 Free PMC article.
VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.
Li X, Padhan N, Sjöström EO, Roche FP, Testini C, Honkura N, Sáinz-Jaspeado M, Gordon E, Bentley K, Philippides A, Tolmachev V, Dejana E, Stan RV, Vestweber D, Ballmer-Hofer K, Betsholtz C, Pietras K, Jansson L, Claesson-Welsh L. Li X, et al. Among authors: tolmachev v. Nat Commun. 2016 Mar 23;7:11017. doi: 10.1038/ncomms11017. Nat Commun. 2016. PMID: 27005951 Free PMC article.
Pretargeted Imaging and Therapy.
Altai M, Membreno R, Cook B, Tolmachev V, Zeglis BM. Altai M, et al. Among authors: tolmachev v. J Nucl Med. 2017 Oct;58(10):1553-1559. doi: 10.2967/jnumed.117.189944. Epub 2017 Jul 7. J Nucl Med. 2017. PMID: 28687600 Free PMC article. Review.
Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model.
Mitran B, Güler R, Roche FP, Lindström E, Selvaraju RK, Fleetwood F, Rinne SS, Claesson-Welsh L, Tolmachev V, Ståhl S, Orlova A, Löfblom J. Mitran B, et al. Among authors: tolmachev v. Theranostics. 2018 Aug 7;8(16):4462-4476. doi: 10.7150/thno.24395. eCollection 2018. Theranostics. 2018. PMID: 30214632 Free PMC article.
Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates.
Ding H, Altai M, Rinne SS, Vorobyeva A, Tolmachev V, Gräslund T, Orlova A. Ding H, et al. Among authors: tolmachev v. Cancers (Basel). 2019 Aug 14;11(8):1168. doi: 10.3390/cancers11081168. Cancers (Basel). 2019. PMID: 31416167 Free PMC article.
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer.
Mitran B, Varasteh Z, Abouzayed A, Rinne SS, Puuvuori E, De Rosa M, Larhed M, Tolmachev V, Orlova A, Rosenström U. Mitran B, et al. Among authors: tolmachev v. Cancers (Basel). 2019 Sep 14;11(9):1371. doi: 10.3390/cancers11091371. Cancers (Basel). 2019. PMID: 31540122 Free PMC article.
Basic and practical concepts of radiopharmaceutical purification methods.
Molavipordanjani S, Tolmachev V, Hosseinimehr SJ. Molavipordanjani S, et al. Among authors: tolmachev v. Drug Discov Today. 2019 Jan;24(1):315-324. doi: 10.1016/j.drudis.2018.09.018. Epub 2018 Sep 29. Drug Discov Today. 2019. PMID: 30278224 Review.
Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1.
Deyev SM, Vorobyeva A, Schulga A, Abouzayed A, Günther T, Garousi J, Konovalova E, Ding H, Gräslund T, Orlova A, Tolmachev V. Deyev SM, et al. Among authors: tolmachev v. Int J Biol Macromol. 2020 Feb 15;145:216-225. doi: 10.1016/j.ijbiomac.2019.12.147. Epub 2019 Dec 19. Int J Biol Macromol. 2020. PMID: 31863835 Free article.
Comparative evaluation of affibody- and antibody fragments-based CAIX imaging probes in mice bearing renal cell carcinoma xenografts.
Garousi J, Huizing FJ, Vorobyeva A, Mitran B, Andersson KG, Leitao CD, Frejd FY, Löfblom J, Bussink J, Orlova A, Heskamp S, Tolmachev V. Garousi J, et al. Among authors: tolmachev v. Sci Rep. 2019 Oct 17;9(1):14907. doi: 10.1038/s41598-019-51445-w. Sci Rep. 2019. PMID: 31624303 Free PMC article.
221 results
Jump to page
Feedback